Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01933724 · ClinicalTrials.gov registry record · Phase 3
The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
A Phase 3 study of Vasculitis and Granulomatosis With Polyangiitis, sponsored by University of South Florida.
- Active
- Registry status
- Phase 3
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT01933724 is a Phase 3 study of Vasculitis and Granulomatosis With Polyangiitis that is active but no longer recruiting, run by University of South Florida. The registered enrollment target is 12 participants, below the 27,318-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01933724, a Phase 3 study of Vasculitis and Granulomatosis With Polyangiitis, is active but no longer recruiting, sponsored by University of South Florida.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial in patients with a diagnosis of granulomatosis with polyangiitis (GPA; Wegener's)that are in remission to evaluate the effects of using low-dose glucocorticoids ( 5 mg/day of prednisone) as compared to stopping glucocorticoid treatment entirely (0 mg/day of prednisone)on rates of disease relapse/disease flares. This study is a novel approach to conducting a randomized clinical trial in the community setting. This study is being conducted in parallel with a similar study at established vasculitis institutions. This study will have a patient centric approach to research in that subjects will be recruited online and through social media and vasculitis support networks. Participants will be consented online and will receive care through their regular treating physician so no travel or additional doctor visits are required. Study participants will consent to the study and complete online questionnaires about their prednisone dose and about how they are feeling.
Conditions Studied
Interventions
- DRUG 5 mg prednisone
- DRUG 0 mg prednisone
Study Locations (1)
Florida
- University of South Florida TAPIR Study Team - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-02-17 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01933724
The ClinicalTrials.gov registry entry for NCT01933724 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 27,318-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Vasculitis appearing as the primary indexed condition, and to 2 interventions - of which 5 mg prednisone is the first listed.
NCT01933724 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01933724 about?
NCT01933724 is a clinical study titled "The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach". This is a randomized controlled trial in patients with a diagnosis of granulomatosis with polyangiitis (GPA; Wegener's)that are in remission to evaluate the effects of using low-dose glucocorticoids ( 5 mg/day of prednisone) as compared to stopping glucocorticoid treatment entirely (0 mg/day of pred...
What is the current status of trial NCT01933724?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 12 participants. The study started on 2014-02-17. Estimated completion is 2025-12-31.
What conditions does trial NCT01933724 study?
This clinical trial studies the following conditions: Vasculitis, Granulomatosis With Polyangiitis, Wegener Granulomatosis.
What interventions are being tested in trial NCT01933724?
The interventions under investigation include: 5 mg prednisone (DRUG), 0 mg prednisone (DRUG).
Who is sponsoring clinical trial NCT01933724?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01933724 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vasculitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
RECRUITING · Phase 3
-
Longitudinal Study for Relapsing Polychondritis
RECRUITING
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
RECRUITING
-
Vasculitis Pregnancy Registry
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.